FDA Inspection 1266205 — Maria Cristina De Salvo, M.D., Ph.D.
The FDA completed an inspection of Maria Cristina De Salvo, M.D., Ph.D. on March 21, 2025 in Ciudad Autonoma De Buenos Aires. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 21, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Ciudad Autonoma De Buenos Aires (Argentina)
Additional Details
Clinical Investigator (CI)